Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marsha Y Morgan

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
The Cochrane Database of Systematic Reviews|August 11, 2017
Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathyEe Teng Goh, Mette L Andersen, Marsha Y Morgan, et al.
The American Journal of Gastroenterology|January 8, 2010
Melatonin rhythms in patients with cirrhosisSara Montagnese, Benita Middleton, Ali R Mani, et al.
Journal of Hepatology|December 8, 2010
Changes in the 24-h plasma cortisol rhythm in patients with cirrhosisSara Montagnese, Benita Middleton, Ali R Mani, et al.
Metabolic Brain Disease|September 17, 2009
Sleep and circadian abnormalities in patients with cirrhosis: features of delayed sleep phase syndrome?Sara Montagnese, Benita Middleton, Ali R Mani, et al.
The American Journal of Gastroenterology|March 25, 2010
On the origin and the consequences of circadian abnormalities in patients with cirrhosisSara Montagnese, Benita Middleton, Ali R Mani, et al.
Journal of Gastroenterology|December 10, 2009
Hepatic encephalopathy: you should only comment on what you have actually measuredSara Montagnese, Sami Schiff, Angelo Gatta, et al.
The American Journal of Clinical Nutrition|November 10, 2006
Two-component models are of limited value for the assessment of body composition in patients with cirrhosisMarsha Y Morgan, Angela M Madden, Graham Jennings, et al.
Journal of Hepatology|December 16, 2017
Reply to: "The PNPLA3 SNP rs738409:G allele is associated with increased liver disease-associated mortality but reduced overall mortality in a population-based cohort"Stephen R Atkinson, Michael J Way, Andrew McQuillin, et al.
Journal of Hepatology|February 6, 2017
Homozygosity for rs738409:G in PNPLA3 is associated with increased mortality following an episode of severe alcoholic hepatitisStephen R Atkinson, Michael J Way, Andrew McQuillin, et al.
Chronobiology International|September 30, 2014
Assessment of 6-sulfatoxymelatonin rhythms and melatonin response to light in disease states: lessons from cirrhosisSara Montagnese, Benita Middleton, Michela Corrias, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
The Cochrane Database of Systematic Reviews|August 11, 2017
Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathyEe Teng Goh, Mette L Andersen, Marsha Y Morgan, et al.
The American Journal of Gastroenterology|January 8, 2010
Melatonin rhythms in patients with cirrhosisSara Montagnese, Benita Middleton, Ali R Mani, et al.
Journal of Hepatology|December 8, 2010
Changes in the 24-h plasma cortisol rhythm in patients with cirrhosisSara Montagnese, Benita Middleton, Ali R Mani, et al.
Metabolic Brain Disease|September 17, 2009
Sleep and circadian abnormalities in patients with cirrhosis: features of delayed sleep phase syndrome?Sara Montagnese, Benita Middleton, Ali R Mani, et al.
The American Journal of Gastroenterology|March 25, 2010
On the origin and the consequences of circadian abnormalities in patients with cirrhosisSara Montagnese, Benita Middleton, Ali R Mani, et al.
Journal of Gastroenterology|December 10, 2009
Hepatic encephalopathy: you should only comment on what you have actually measuredSara Montagnese, Sami Schiff, Angelo Gatta, et al.
The American Journal of Clinical Nutrition|November 10, 2006
Two-component models are of limited value for the assessment of body composition in patients with cirrhosisMarsha Y Morgan, Angela M Madden, Graham Jennings, et al.
Journal of Hepatology|December 16, 2017
Reply to: "The PNPLA3 SNP rs738409:G allele is associated with increased liver disease-associated mortality but reduced overall mortality in a population-based cohort"Stephen R Atkinson, Michael J Way, Andrew McQuillin, et al.
Journal of Hepatology|February 6, 2017
Homozygosity for rs738409:G in PNPLA3 is associated with increased mortality following an episode of severe alcoholic hepatitisStephen R Atkinson, Michael J Way, Andrew McQuillin, et al.
Chronobiology International|September 30, 2014
Assessment of 6-sulfatoxymelatonin rhythms and melatonin response to light in disease states: lessons from cirrhosisSara Montagnese, Benita Middleton, Michela Corrias, et al.
Pageof 9